Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/329735
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases |
Autor: | Queiroz, Aline Maria Vasconcelos; Oliveira, Johny Wysllas de Freitas; Moreno, Cláudia Jassica; Guérin, Diego M. A. CSIC ORCID; Silva, Marcelo Sousa | Palabras clave: | African trypanosomiasis Chagas disease Leishmaniasis Trypanosomatids Vaccine Virus-like particles |
Fecha de publicación: | 5-mar-2021 | Editor: | Multidisciplinary Digital Publishing Institute | Citación: | Vaccines 9(3): 220 (2021) | Resumen: | Research on vaccines against trypanosomatids, a family of protozoa that cause neglected tropical diseases, such as Chagas disease, leishmaniasis, and sleeping sickness, is a current need. Today, according to modern vaccinology, virus-like particle (VLP) technology is involved in many vaccines, including those undergoing studies related to COVID-19. The potential use of VLPs as vaccine adjuvants opens an opportunity for the use of protozoan antigens for the development of vaccines against diseases caused by Trypanosoma cruzi, Leishmania spp., and Trypanosoma brucei. In this context, it is important to consider the evasion mechanisms of these protozoa in the host and the antigens involved in the mechanisms of the parasite-host interaction. Thus, the immunostimulatory properties of VLPs can be part of an important strategy for the development and evaluation of new vaccines. This work aims to highlight the potential of VLPs as vaccine adjuvants for the development of immunity in complex diseases, specifically in the context of tropical diseases caused by trypanosomatids. | Versión del editor: | https://doi.org/10.3390/vaccines9030220 | URI: | http://hdl.handle.net/10261/329735 | DOI: | 10.3390/vaccines9030220 | E-ISSN: | 2076-393X |
Aparece en las colecciones: | (IBF) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
VLP_Based_Vaccines_Queiroz.pdf | 642,31 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
4
checked on 03-may-2024
SCOPUSTM
Citations
7
checked on 29-abr-2024
WEB OF SCIENCETM
Citations
6
checked on 22-feb-2024
Page view(s)
26
checked on 05-may-2024
Download(s)
8
checked on 05-may-2024